What is the current valuation of the UK percutaneous coronary-intervention market?

The market valuation was $643.28 Million in 2024. Read More

What is the projected market size for the UK percutaneous coronary-intervention market by 2035?

The market is projected to reach $1836.0 Million by 2035. Read More

What is the expected CAGR for the UK percutaneous coronary-intervention market during the forecast period 2025 - 2035?

The expected CAGR is 10.0% during the forecast period. Read More

Which product segment holds the highest valuation in the UK percutaneous coronary-intervention market?

Coronary Stents held a valuation of $150.0 Million in 2024 and is expected to grow significantly. Read More

What are the key players in the UK percutaneous coronary-intervention market?

Key players include Abbott Laboratories, Boston Scientific Corporation, and Medtronic plc, among others. Read More

How do the vascular access segments compare in terms of market valuation?

The Femoral segment had a valuation of $385.97 Million in 2024, while the Radial segment was valued at $257.31 Million. Read More

What is the market valuation for hospitals and clinics as end users in the UK percutaneous coronary-intervention market?

Hospitals & Clinics had a valuation of $386.28 Million in 2024. Read More

What is the expected growth trajectory for the coronary guidewires segment?

The coronary guidewires segment was valued at $80.0 Million in 2024 and is likely to see substantial growth. Read More

What is the valuation of the inflation device segment in the UK percutaneous coronary-intervention market?

The inflation device segment was valued at $30.0 Million in 2024. Read More

What is the projected growth for ambulatory surgical centers as end users by 2035?

Ambulatory Surgical Centers are projected to grow from $157.0 Million in 2024 to a higher valuation by 2035. Read More

UK Percutaneous Coronary Intervention Market

ID: MRFR/HC/43692-HCR

200 Pages

Satyendra Maurya

Last Updated: April 06, 2026

UK Percutaneous Coronary Intervention Market Research Report By Product Type (Coronary Stents, Ballon Catheters, Coronary Guidewires, Guiding Catheters, Guiding Sheaths, Diagnostic Catheters, Crossing Catheters, Inflation Device, Guidance System, Peripheral Thrombectomy System, Embolic Protection System, Accessories), By Vascular Access (Radial, Femoral) and By End User (Hospitals Clinics, Ambulatory Surgical Centers, Others) -Forecast to 2035

UK Percutaneous Coronary Intervention Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Product Type (USD Million)
  1. 4.1.1 Coronary Stents
  2. 4.1.2 Balloon Catheters
  3. 4.1.3 Coronary Guidewires
  4. 4.1.4 Guiding Catheters
  5. 4.1.5 Guiding Sheaths
  6. 4.1.6 Diagnostic Catheters
  7. 4.1.7 Crossing Catheters
  8. 4.1.8 Inflation Device
  9. 4.1.9 Guidance System
  10. 4.1.10 Peripheral Thrombectomy System
  11. 4.1.11 Embolic Protection System
  12. 4.1.12 Accessories
2. 4.2 Chemicals and Materials, BY Vascular Access (USD Million)
  1. 4.2.1 Radial
  2. 4.2.2 Femoral
3. 4.3 Chemicals and Materials, BY End User (USD Million)
  1. 4.3.1 Hospitals & Clinics
  2. 4.3.2 Ambulatory Surgical Centers
  3. 4.3.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific Corporation (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Medtronic plc (IE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 B. Braun Melsungen AG (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Terumo Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cardinal Health, Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Siemens Healthineers AG (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 UK MARKET ANALYSIS BY VASCULAR ACCESS
4. 6.4 UK MARKET ANALYSIS BY END USER
5. 6.5 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF CHEMICALS AND MATERIALS
8. 6.8 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
9. 6.9 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
11. 6.11 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 (% SHARE)
12. 6.12 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
13. 6.13 CHEMICALS AND MATERIALS, BY VASCULAR ACCESS, 2024 (% SHARE)
14. 6.14 CHEMICALS AND MATERIALS, BY VASCULAR ACCESS, 2024 TO 2035 (USD Million)
15. 6.15 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
16. 6.16 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY VASCULAR ACCESS, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Chemicals and Materials Market Segmentation

Chemicals and Materials By Product Type (USD Million, 2025-2035)

Coronary Stents
Balloon Catheters
Coronary Guidewires
Guiding Catheters
Guiding Sheaths
Diagnostic Catheters
Crossing Catheters
Inflation Device
Guidance System
Peripheral Thrombectomy System
Embolic Protection System
Accessories

Chemicals and Materials By Vascular Access (USD Million, 2025-2035)

Radial
Femoral

Chemicals and Materials By End User (USD Million, 2025-2035)

Hospitals & Clinics
Ambulatory Surgical Centers
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”